AngelHuang

Partner-in-Charge Shanghai

Shanghai + 86.21.2201.8000 Beijing + 86.10.5866.1125

Angel Huang, who serves as Jones Day's Shanghai Partner-in-Charge and M&A Chair for Asia, focuses her practice on cross-border M&A transactions, foreign direct investments (FDIs), private equity and venture capital transactions, and strategic investments. She has more than a decade of experience practicing in China. Angel represents clients in a broad range of sectors, including manufacturing, aviation, financial services, technology, biotech and pharmaceuticals, education, e-commerce, energy, and automotive.

Angel has extensive experience in Chinese outbound transactions where she represents both Chinese companies in their acquisitions overseas and foreign targets of Chinese outbound acquisitions. In particular, she works closely with Jones Day U.S. regulatory lawyers on the key issues involved with most Chinese outbound investments in the United States, for example, CFIUS, U.S. export control, and economic sanctions issues. She has first-hand experience regarding current hurdles to Chinese companies involving their investment worldwide and can advise clients based on her valuable local experience. She recently represented Chinese companies along, with U.S. government regulation lawyers, on U.S. export control and sanction matters. In addition, she represents clients in their acquisitions of Hong Kong-listed companies and on compliance issues, working with the Firm's capital markets team in Hong Kong.

Apart from M&A work, Angel advises leading Chinese financial institutions in financing transactions, especially on mezzanine and acquisition financings in various structures.

Angel is a member of the American Bar Association and the New York State Bar Association. She is also an adjunct professor at the University of North Alabama's Executive MBA program in Suzhou and Changzhou, China, where she teaches courses on M&A and corporate governance.

Experience

  • Huadong Medicine enters co-development partnership with Exscientia to accelerate oncology drug discovery through AIJones Day advised Huadong Medicine Co. Ltd. in the negotiation and signing of a research cooperation agreement with Exscientia, a world-leading, clinical-stage Artificial Intelligence (AI) drug discovery company.
  • SunPower closes sponsored spin-off of solar panel production operationsJones Day advised SunPower Corporation (NASDAQ: SPWR), one of North America's largest solar-panel makers, in a sponsored spin-off of its solar panel production operations into a new public company – Maxeon Solar Technologies – which will be headquartered in Singapore.
  • PolyOne acquires Clariant color and additive masterbatch business for $1.5 billionJones Day advised PolyOne Corporation in the $1.5 billion purchase of Clariant’s global color and additive masterbatch business.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • Synaptics divests LCD TDDI business to Hua Capital for $139.4 millionJones Day advised Synaptics Incorporated in its $139.4 million divestiture of its Asia-based mobile LCD TDDI Business to an affiliate of Hua Capital.
  • Shanghai Zhenge Biotech raises $51 million in Series A roundJones Day represented Shanghai Zhenge Biotech Co., Ltd., a Shanghai-based CDMO (“Contract Development and Manufacturing Organization”) company for biotech companies developing antibodies and other protein drugs, in connection with the $51 million Series A round of financing led by LYFE Capital.
  • Chinese financial leasing company provides $15 million loan to KateevaJones Day represented a Chinese financial leasing company in connection with its $15 million loan provided to Kateeva Inc., a developer of the world's first inkjet printer to manufacture high volumes of flexible OLEDs (organic electroluminescent diodes).
  • CWT sold Dongguan Hillview Golf Company to Hillview Holdings LimitedJones Day advised CWT International Limited, a public company listed in the Hong Kong Stock Exchange, in the HK$180 million sale of its 65% indirectly held equity interest in Dongguan Hillview Golf Company Limited to Hillview Holdings Limited.
  • China Orient Asset Management provides financing for luxury condominium building in lower ManhattanJones Day advised China Orient Asset Management (International) Holdings Limited (“COAMI”) in connection with a junior mezzanine loan secured by a majority membership interest in a real estate joint venture (the “Venture”).
  • Sumitomo Heavy Industries acquires InvertekJones Day advised Sumitomo Heavy Industries, Ltd. in the acquisition of the entire issued share capital of Invertek Drives Ltd.
  • LORD Corporation acquired by Parker Hannifin for $3.675 billionJones Day advised LORD Corporation in its $3.675 billion acquisition by Parker Hannifin Corporation.
  • PolyOne sells its Performance Products and Solutions business to SK Capital Partners for $775 millionJones Day advised PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, in its $775 million cash sale of its Performance Products and Solutions business to SK Capital Partners.
  • PETRONAS Chemicals acquires Da Vinci Group B.V. for €163 millionJones Day advised PETRONAS Chemicals Group Berhad (PCG) in its acquisition of a 100% stake in Da Vinci Group B.V. from its shareholders including funds managed by Bencis Capital Partners for €163 million.
  • Western Digital acquires Kazan NetworksJones Day advised Western Digital Corporation (NASDAQ:WDC) in its acquisition of Kazan Networks Corp., a provider of industry leading NVMe™-over-Fabric (NVMe-oF) ASIC and adapter products for next-generation data center architectures.
  • AURELIUS sells Solidus Solutions for €330 million (US$375.6 million)Jones Day advised AURELIUS Equity Opportunities SE & Co. KGaA on the full shop auction sale of the Solidus Solutions group to funds advised by Centerbridge Partners, L.P.
  • CIRCOR sells Pibiviesse S.p.A. to CERTINAJones Day advised CIRCOR International, Inc. in the sale of its Italian long-cycle upstream oil and gas engineered valve business (Pibiviesse S.p.A.) to P&P Flow Control, an affiliate of Certina Holding AG.
  • Chroma acquires 20.5% of CamtekJones Day advised Chroma ATE Inc., a leading Taiwanese corporation, in its acquisition of approximately 20.5% of the shares of Camtek Ltd. at $9.50 per share.
  • Huadong Medicine invests in R2 Dermatology and enters into distribution agreementJones Day advised Huadong Medicine Co. Ltd., a Chinese manufacturer and distributor of pharmaceutical and other medical products, in connection with its subscription of Series B Preferred Shares of R2 Dermatology, Inc., and the negotiation of a distribution agreement authorizing Huadong Medicine as an exclusive distributor in Asia for R2's skin whitening products.
  • INVISTA sells Apparel & Advanced Textiles business to Shandong Ruyi Investment HoldingJones Day advised INVISTA, a subsidiary of Koch Industries, Inc., in its sale of INVISTA’s Apparel & Advanced Textiles business to Shandong Ruyi Investment Holding.
  • Shenglong Technologies reaches settlement against former broker in U.S. district courtJones Day represented Ningbo Superim Shenglong Technologies Co., Ltd. and its parent company, Yinyi Group Co., Ltd. in U.S. district court against Shenglong's former broker in a factory acquisition.
  • Speaking Engagements

    • January 26, 2016
      CLE Academy Shanghai 2016
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.